Rapamycin News

Rapamycin News

Publication
0 followers

Community-driven news and discussion focused on rapamycin and related longevity interventions.

Vaccines for Longevity
NewsMay 4, 2026

Vaccines for Longevity

A forum member received the Shingrix shingles vaccine 12 days after a 6 mg dose of Rapamune (sirolimus) and experienced pronounced flu‑like side effects. Participants debated whether the timing was optimal, noting rapamycin’s dual role as an immune modulator that can...

By Rapamycin News
GERD, PPI Use and Longevity
NewsMay 3, 2026

GERD, PPI Use and Longevity

A personal protocol for managing GERD and reducing reliance on proton‑pump inhibitors (PPIs) centers on citrate chemistry and diet. The regimen combines 800 mg magnesium citrate, 600 mg calcium citrate, and half a teaspoon of sodium citrate twice daily, alongside a Mediterranean...

By Rapamycin News
Out of 400 Drugs, Only These Might Help You Live Longer - Dr. Kevin Perez and Siim Land
NewsMay 3, 2026

Out of 400 Drugs, Only These Might Help You Live Longer - Dr. Kevin Perez and Siim Land

A UK Biobank study of 500,000 participants tracked medication use for up to 20 years and compared users of 400+ drugs with matched controls. After adjusting for demographics, health status and socioeconomic factors, only fourteen drugs showed a statistically significant...

By Rapamycin News
The Plasticization of Human Longevity: Are Microplastics the New Gerontogens?
NewsMay 3, 2026

The Plasticization of Human Longevity: Are Microplastics the New Gerontogens?

A new review in the Journal of Xenobiotics argues that micro‑ and nanoplastics (MNPs) accumulate in human tissues and act as systemic gerontogens, accelerating biological aging. By age 70, an average person could carry over 50,000 plastic particles, a load...

By Rapamycin News
After Heart Attack, Therapeutic Plasma Exchange (TPE) Rescues the Aging Heart
NewsMay 3, 2026

After Heart Attack, Therapeutic Plasma Exchange (TPE) Rescues the Aging Heart

Researchers at UC Berkeley demonstrated that therapeutic plasma exchange (TPE) performed 24 hours after a heart attack can nearly reverse damage in aged mice, the equivalent of humans in their 60s. By replacing half of the plasma with saline‑albumin solution, the...

By Rapamycin News
Update on Brad Stanfield's Rapamycin Clinical Study in NZ
NewsMay 1, 2026

Update on Brad Stanfield's Rapamycin Clinical Study in NZ

Brad Stanfield’s New Zealand rapamycin trial enrolled older adults on a 12‑week protocol, with participants typically taking 6 mg every other week. The study measured functional outcomes such as the chair‑stand test, sparking debate over whether short‑term dosing can reveal longevity benefits. Commentators...

By Rapamycin News
Anyone Taking Rapamycin Monthly?
NewsMay 1, 2026

Anyone Taking Rapamycin Monthly?

A growing community of longevity enthusiasts is experimenting with monthly rapamycin dosing, typically ranging from 5 mg to 30 mg and often boosted with grapefruit juice. Participants cite benefits such as fewer infections and slower aging markers, but also report side effects...

By Rapamycin News
Do ARBs Increase Cancer Risk?
NewsMay 1, 2026

Do ARBs Increase Cancer Risk?

A recent Mendelian randomization study provides genetic evidence that ACE inhibitors and ARBs, including losartan, lower the risk of several cancers such as gastric, colorectal, lung, breast, and endometrial. Losartan is marketed for hypertension and kidney protection without the cough...

By Rapamycin News
XPRIZE Healthspan Names Top 100 Teams Advancing Healthy Aging
NewsApr 30, 2026

XPRIZE Healthspan Names Top 100 Teams Advancing Healthy Aging

The XPRIZE Healthspan competition announced its top 100 teams, spotlighting the core innovations of the 40 Milestone 1 award‑winning entrants. These teams are pursuing a spectrum of strategies—from mitochondrial‑targeted small molecules and metformin‑rapamycin combos to AI‑driven nutrition plans, senolytic drugs, and...

By Rapamycin News
Does Anyone Take ADHD Stimulant Meds (Adderall, Vyvanse)? Tips on Reducing Neurotoxicity Risk?
NewsApr 30, 2026

Does Anyone Take ADHD Stimulant Meds (Adderall, Vyvanse)? Tips on Reducing Neurotoxicity Risk?

Recent discussions highlight that ADHD may involve more than neurotransmitter imbalance, with oxidative stress and mitochondrial dysfunction playing key roles. Stimulant medications such as amphetamines boost dopamine turnover, which can increase reactive oxygen species and strain mitochondrial energy production. Users...

By Rapamycin News
Cardiovascular Health 2026
NewsApr 30, 2026

Cardiovascular Health 2026

Recent studies highlight pitavastatin’s pleiotropic benefits beyond LDL‑C reduction, including functional HDL elevation, enhanced cholesterol‑efflux capacity, and antioxidative actions in dyslipidemic patients. Pre‑clinical work shows the drug strengthens blood‑brain barrier integrity and mitigates lipopolysaccharide‑induced BBB dysfunction, suggesting neuroprotective potential. Real‑world...

By Rapamycin News
Generally Good Indian Pharma Companies
NewsApr 30, 2026

Generally Good Indian Pharma Companies

An audit of top‑tier Indian generic manufacturers evaluated options for 20 therapeutic compounds, ranking firms by market capitalization, API vertical integration, ANDA volume, and GMP compliance. Cipla, Abbott, Sun Pharma, Zydus, Biocon and others were highlighted for specific products such...

By Rapamycin News
Peptides / Bioregulators
NewsApr 28, 2026

Peptides / Bioregulators

The AGI House in San Francisco hosted the inaugural California Peptide Club, drawing over 100 invite‑only attendees to discuss self‑optimization peptides. Organiser Julius Ritter highlighted the fragmented information landscape and showcased stacks ranging from growth‑hormone releasers to cognitive enhancers. Days later, HHS...

By Rapamycin News
FOXO4-DRI Is Fascinating, but Was Never Intended for Human Use, What Are the Takeaways?
NewsApr 28, 2026

FOXO4-DRI Is Fascinating, but Was Never Intended for Human Use, What Are the Takeaways?

FOXO4‑DRI is an experimental senolytic peptide that selectively eliminates senescent cells by disrupting the FOXO4‑p53 interaction, prompting p53‑mediated apoptosis. Pre‑clinical studies across vascular, reproductive, musculoskeletal and renal models report improved endothelial function, restored testosterone production, chondrocyte rejuvenation, and reduced frailty....

By Rapamycin News
Peptides / Bioregulators
NewsApr 28, 2026

Peptides / Bioregulators

A new study examined 6,441 gray‑market peptide samples covering 14 compounds, measuring purity, dose accuracy, and endotoxin levels. Between 41.6% and 71.1% of the products failed basic pharmaceutical standards, and 2.4% contained no active peptide at all. Endotoxin contamination appeared...

By Rapamycin News
Semiglutide Regenerates Cartilage Loss Through Weight Loss Independent Metabolic Restoration Mechanism
NewsApr 28, 2026

Semiglutide Regenerates Cartilage Loss Through Weight Loss Independent Metabolic Restoration Mechanism

Semaglutide, a GLP‑1 receptor agonist originally developed for diabetes, is showing promise as a cartilage‑regenerating therapy. Preclinical pair‑fed mouse studies demonstrate cartilage protection independent of weight loss, while a 24‑week pilot in humans reported a 17% increase in cartilage thickness....

By Rapamycin News
HIV Drug (Maraviroc) Reverses Muscle Aging by Purging “Zombie Cell” Signals
NewsApr 28, 2026

HIV Drug (Maraviroc) Reverses Muscle Aging by Purging “Zombie Cell” Signals

Researchers are exploring the HIV CCR5 antagonist maraviroc as a senomorphic agent that could blunt muscle aging by dampening chronic SASP signaling. Modeling suggests a 75 mg once‑daily dose achieves high CCR5 occupancy, but human data on sarcopenia are absent. The...

By Rapamycin News
Importing Rapamycin to Save Money (2)
NewsApr 28, 2026

Importing Rapamycin to Save Money (2)

A community member placed a test order for sirolimus tablets from RL Pharma Jagdish in India via IndiaMart.com, paying a $25 wire transfer. The package left on Oct 16 2025 and arrived after 26 days on Nov 10 2025, experiencing delays in Zurich, JFK customs,...

By Rapamycin News
Rapamycin and Psoriasis
NewsApr 27, 2026

Rapamycin and Psoriasis

Rapamycin, an mTOR inhibitor used for longevity, is being discussed as a possible psoriasis treatment. The forum post highlights oral versus topical administration, noting early positive skin‑aging results for topical use but no definitive clinical evidence for psoriasis clearance. Users...

By Rapamycin News
Sleep Supplements: What Is Most Effective, Least Habit Forming, and Safest?
NewsApr 27, 2026

Sleep Supplements: What Is Most Effective, Least Habit Forming, and Safest?

Recent research highlights orexin hyperactivity as a core driver of PTSD‑related insomnia, linking stress‑induced orexin release to REM fragmentation and persistent fear memories. Traditional sedatives often disrupt sleep architecture, whereas dual orexin receptor antagonists (DORAs) such as suvorexant and daridorexant...

By Rapamycin News
Ivermectin: The New Wonder Drug?
NewsApr 27, 2026

Ivermectin: The New Wonder Drug?

A new consortium paper from Texas institutions challenges the long‑standing hygiene hypothesis that helminths are essential for immune maturation. The authors show that common roundworms and Toxocara remain prevalent in low‑income U.S. communities and are linked to worse asthma and...

By Rapamycin News
The Cure for Death Means Billionaires Will Live Forever—And Be Rich Forever
NewsApr 27, 2026

The Cure for Death Means Billionaires Will Live Forever—And Be Rich Forever

U.S. billionaires enjoy a dramatically higher life expectancy, with 20% living past 80 compared to just 3.8% of the general population. Their longevity stems from access to premium healthcare, personal trainers, and cutting‑edge nutrition. Meanwhile, leaders like Putin and Xi...

By Rapamycin News
Free Radicals Podcast (Longevity / Biotech Oriented)
NewsApr 27, 2026

Free Radicals Podcast (Longevity / Biotech Oriented)

Kexin Huang, the a16z‑backed founder of Pho, argues that biology is entering an "Agentic Biology" era where AI agents orchestrate research rather than merely analyze data. His Integrated Biology Environment (IBE), embodied in the Biomni platform, acts like an IDE...

By Rapamycin News
Free Radicals Podcast (Longevity / Biotech Oriented)
NewsApr 27, 2026

Free Radicals Podcast (Longevity / Biotech Oriented)

Nathan Cheng argues that aging remains untreated due to a coordination failure rooted in cultural "deathism," despite roughly 100,000 daily deaths from age‑related diseases. He highlights a stark $5 B versus $100 B+ funding gap between longevity and cancer research, underscoring the...

By Rapamycin News
Parkinson's Disease
NewsApr 25, 2026

Parkinson's Disease

A recent randomized controlled trial found that daily resistant starch supplementation alleviated motor symptoms in Parkinson’s disease patients. Over a 12‑week period, participants showed a 15% reduction in Unified Parkinson’s Disease Rating Scale (UPDRS) motor scores compared with placebo. The...

By Rapamycin News
HIV Medication Reverses Epigenetic Aging Markers in First Human Proof-of-Concept Trial
NewsApr 25, 2026

HIV Medication Reverses Epigenetic Aging Markers in First Human Proof-of-Concept Trial

A proof‑of‑concept trial found that the HIV pre‑exposure drug FTC/TAF (Descovy) significantly reduced several epigenetic aging clocks in healthy adults, with declines of up to 3.4 years in heart, brain and metabolic markers. The molecular data showed an improved immune...

By Rapamycin News
The Rich and Powerful Want to Live Forever. What if They Could?
NewsApr 25, 2026

The Rich and Powerful Want to Live Forever. What if They Could?

President Vladimir Putin has formalized a multi‑year, $26 billion National Project to develop anti‑aging therapies, aiming to extend healthy life expectancy for 175,000 Russians by 2030. The initiative, overseen by Kurchatov Institute director Mikhail Kovalchuk, targets sarcopenia, osteoporosis, cognitive decline and...

By Rapamycin News
This Nasal Spray Rewinds the Aging Brain, Restoring Memory and Reversing Inflammation in Preclinical Models
NewsApr 23, 2026

This Nasal Spray Rewinds the Aging Brain, Restoring Memory and Reversing Inflammation in Preclinical Models

Researchers at Texas A&M have created an intranasal spray containing extracellular vesicles derived from human induced pluripotent stem cell‑derived neural stem cells. In 18‑month‑old mice, equivalent to 60‑year‑old humans, two doses dramatically reduced hippocampal inflammation, restored mitochondrial function in microglia,...

By Rapamycin News
Brad Stanfield Rapamycin Trials
NewsApr 23, 2026

Brad Stanfield Rapamycin Trials

Brad Stanfield’s recent clinical study found that participants receiving a placebo performed better than those given rapamycin, a drug touted for its anti‑aging potential. The unexpected outcome was reported within hours of the trial’s completion, prompting immediate scrutiny from the...

By Rapamycin News
New Study Reveals CRISPR Enzyme that Responds to Human DNA Methylation
NewsApr 22, 2026

New Study Reveals CRISPR Enzyme that Responds to Human DNA Methylation

A collaborative team from Wageningen University & Research and the Van Andel Institute has identified a CRISPR-associated enzyme that senses DNA methylation, a key epigenetic mark distinguishing cancer cells from normal tissue. The enzyme selectively binds to methylated human DNA,...

By Rapamycin News
The Great Unbalding. Fallen Follicles, Rise! (NY Mag)
NewsApr 22, 2026

The Great Unbalding. Fallen Follicles, Rise! (NY Mag)

Scientists at Pelage Pharmaceuticals unveiled PP405, a novel drug that reprograms dormant hair‑follicle stem cells to regrow thick hair on balding scalp. Early Phase 2a data released in June 2024 showed rapid regrowth in areas previously considered irreversibly lost, sparking intense...

By Rapamycin News
Prostate Cancer - I’m Asking for some Specific Advice/Thoughts to Determine My Physical (Cell-Level Age) versus Chronological Age
NewsApr 21, 2026

Prostate Cancer - I’m Asking for some Specific Advice/Thoughts to Determine My Physical (Cell-Level Age) versus Chronological Age

The large TRAVERSE trial of about 5,200 hypogonadal men found no increase in prostate‑cancer incidence with testosterone replacement therapy—12 cases on treatment versus 11 on placebo—though the study’s 33‑month follow‑up and 60% dropout limit statistical power. Mechanistically, androgen‑receptor saturation occurs...

By Rapamycin News
Peptides / Bioregulators
NewsApr 21, 2026

Peptides / Bioregulators

The invite‑only California Peptide Club convened over 100 tech‑savvy attendees in San Francisco to discuss self‑optimization peptides, a trend now outpacing even pickleball in Google searches. Participants, ranging from clinicians to DIY biohackers, shared personal stacks and demonstrated injection techniques...

By Rapamycin News
Iron: An Underrated Factor in Aging
NewsApr 21, 2026

Iron: An Underrated Factor in Aging

The piece argues that excess iron—especially heme iron from animal foods—acts like internal rust, driving oxidative damage through the Fenton reaction and contributing to cardiovascular disease, insulin resistance, and cancer. It highlights that typical ferritin levels in Western populations often...

By Rapamycin News
Dr. Kaeberlein's Optispan Podcast Series - Rapamycin and More
NewsApr 21, 2026

Dr. Kaeberlein's Optispan Podcast Series - Rapamycin and More

The Optispan podcast hosted by Dr. Kaeberlein outlines a translational protocol for 3‑hydroxyanthranilic acid (3HAA), a mouse‑tested longevity molecule. Using FDA BSA scaling, the human equivalent dose (HED) is calculated at roughly 1.1 g per day for a 70‑kg adult. Safety...

By Rapamycin News
'The Chances of You Living 50 Years Are Very Small': Theoretical Physicist Explains Why Humanity Likely Won't Survive to See...
NewsApr 21, 2026

'The Chances of You Living 50 Years Are Very Small': Theoretical Physicist Explains Why Humanity Likely Won't Survive to See...

Nobel laureate David Gross, fresh off a $3 million Special Breakthrough Prize in Fundamental Physics, warned that the odds of a nuclear war hover around 2 % each year, giving humanity an average survival window of roughly 35 years. He linked this...

By Rapamycin News
AGI/ASI Timelines Thread (AGI/ASI May Solve Longevity if It Doesn't "Kill Us All" First)
NewsApr 21, 2026

AGI/ASI Timelines Thread (AGI/ASI May Solve Longevity if It Doesn't "Kill Us All" First)

A new NYU‑led study titled “Tyranny of the Minority” finds that a tiny fraction of social‑media users—about 0.01%—are responsible for 80% of misinformation during the 2016 U.S. election, reshaping public opinion through a trinity of influencers, platform algorithms, and engaged...

By Rapamycin News
AGI/ASI Timelines Thread (AGI/ASI May Solve Longevity if It Doesn't "Kill Us All" First)
NewsApr 21, 2026

AGI/ASI Timelines Thread (AGI/ASI May Solve Longevity if It Doesn't "Kill Us All" First)

Recent reporting highlights accelerating AI capabilities alongside mounting safety and governance concerns. OpenAI has dismantled key safety teams, prompting warnings from experts and a poor safety grade, while data centers now draw roughly 30 GW—enough to power New York—raising environmental alarms....

By Rapamycin News
Why Do Falls Rise with Age? Cerebellar Neuron Firing Problems (and Potential Therapeutics)
NewsApr 19, 2026

Why Do Falls Rise with Age? Cerebellar Neuron Firing Problems (and Potential Therapeutics)

A new McGill University study published in PNAS shows that age‑related motor decline is not due to loss of cerebellar Purkinje neurons but to a drop in their intrinsic firing frequency. The researchers demonstrated that suppressing Purkinje firing in young...

By Rapamycin News
Dasatinib and Quercetin as Senolytic May Cause Brain Damage
NewsApr 19, 2026

Dasatinib and Quercetin as Senolytic May Cause Brain Damage

A March 2026 PNAS study shows that the senolytic combo dasatinib and quercetin (D+Q) triggers demyelination in the corpus callosum of aged mice. The researchers used intermittent oral doses of 5 mg/kg dasatinib and 50 mg/kg quercetin, identical to regimens linked to...

By Rapamycin News
The Longevity Effects of Reduced IGF-1 Signaling Depend on the Stability of the Mitochondrial Genome (Paper April 2026)
NewsApr 19, 2026

The Longevity Effects of Reduced IGF-1 Signaling Depend on the Stability of the Mitochondrial Genome (Paper April 2026)

The study shows that reducing IGF‑1 signaling via Pappa loss does not extend lifespan in Polg D257A mutator mice, which harbor unstable mitochondrial DNA. While Pappa deletion improves several health metrics—splenomegaly, anemia, inflammation, muscle and cardiac function—the longevity benefit seen in...

By Rapamycin News
Robust Mouse Rejuvenation (RMR1) Study Update
NewsApr 19, 2026

Robust Mouse Rejuvenation (RMR1) Study Update

The Robust Mouse Rejuvenation (RMR) program, led by Dr. Aubrey de Grey and the LEV Foundation, is testing multi‑intervention stacks to extend mouse lifespan far beyond the ~4‑month gains seen with single agents. RMR1 combined rapamycin, telomerase gene therapy, heterochronic bone‑marrow...

By Rapamycin News
Is VC6TF the OSK Reversal Cocktail?
NewsApr 19, 2026

Is VC6TF the OSK Reversal Cocktail?

Researchers at the Sinclair Lab have identified a five‑molecule mix called VC6TF that chemically mimics the OSK (Oct4, Sox2, Klf4) gene‑therapy cocktail used to reset cellular age. The core of the “three‑chemical” version discussed by Dr. Sinclair includes CHIR‑99021, RepSox...

By Rapamycin News
Retatrutide - Possibly Better than Semaglutide B/C Lower Nausea/Side Effect Profile, but Higher Heart Rate
NewsApr 18, 2026

Retatrutide - Possibly Better than Semaglutide B/C Lower Nausea/Side Effect Profile, but Higher Heart Rate

Retatrutide, a triple‑agonist peptide, is generating buzz for delivering dramatic weight loss at doses of 8‑12 mg, rivaling semaglutide while causing fewer nausea complaints. Early users note that appetite suppression diminishes after several weeks, yet the drug continues to support weight‑maintenance...

By Rapamycin News
Longevity: What 2 or 3 Other Supplemental Medications Would You Use Along with Rapacan/Sirolimus?
NewsApr 18, 2026

Longevity: What 2 or 3 Other Supplemental Medications Would You Use Along with Rapacan/Sirolimus?

An anonymous forum user seeks supplemental drugs to pair with rapamycin (sirolimus) for longevity, already taking resveratrol. Community responses recommend metformin, acarbose, and SGLT2 inhibitors such as dapagliflozin to counter rapamycin‑induced glucose spikes, plus statins or ezetimibe for lipid control...

By Rapamycin News
Hazel Szeto, SS-31 Peptide, the World's First FDA-Approved Mitochondria-Targeted Drug (Longevity Summit, 2025)
NewsApr 18, 2026

Hazel Szeto, SS-31 Peptide, the World's First FDA-Approved Mitochondria-Targeted Drug (Longevity Summit, 2025)

SS‑31 (elamipretide), the first FDA‑approved mitochondria‑targeted drug, is being promoted on TikTok as a vision enhancer, despite its approval only for a rare mitochondrial disease. Clinical data for age‑related macular degeneration (AMD) show the drug failed to meet endpoints, with...

By Rapamycin News
Imeglimin. A New and Novel Drug Thats Better than Metformin
NewsApr 18, 2026

Imeglimin. A New and Novel Drug Thats Better than Metformin

Imeglimin, a mitochondrial‑targeted antidiabetic agent, is emerging as a novel alternative to metformin. Pre‑clinical studies show it restores mitochondrial function in skeletal muscle and pancreatic β‑cells, enhancing insulin secretion and reducing oxidative stress. Phase‑3 trials report HbA1c reductions of 0.6‑0.9%...

By Rapamycin News
Dietary Interventions for Healthy Aging: An Epigenetic Perspective
NewsApr 16, 2026

Dietary Interventions for Healthy Aging: An Epigenetic Perspective

A new review from Nanjing University of Chinese Medicine argues that diet functions as epigenetic software, supplying metabolites such as SAM, NAD+, α‑ketoglutarate and acetyl‑CoA that directly shape DNA methylation and histone modifications. It dissects three evidence‑backed interventions—Caloric Restriction, the...

By Rapamycin News
Inflammation & Immune System - A Deep Dive Into Genetic Pathways for Actionable Insights
NewsApr 15, 2026

Inflammation & Immune System - A Deep Dive Into Genetic Pathways for Actionable Insights

A detailed genetic analysis of inflammation and immune pathways identified three high‑impact homozygous variants: PTPN22 R620W, CFH Y402H, and NFE2L2 –617. The report translates these findings into concrete clinical actions, including autoimmune and thyroid screening, baseline retinal imaging for age‑related...

By Rapamycin News